20 (AIDX) EBT Margin Growth (1y) (2026)

20 (AIDX) EBT Margin Growth (1y) (2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBT Margin Growth (1y) (Qtr)
1 Abbott Laboratories 182.32 Bn 175.02 Bn 6.27 Bn -419.00
2 Stryker 128.75 Bn 125.88 Bn 3.81 Bn 110.00
3 Medtronic 107.83 Bn 98.61 Bn 6.41 Bn 458.00
4 Boston Scientific 67.61 Bn 66.15 Bn 3.61 Bn 507.00
5 Edwards Lifesciences 48.13 Bn 44.45 Bn 1.29 Bn -287.00
6 Dexcom 28.26 Bn 27.14 Bn 750.30 Mn 772.00
7 GE HealthCare Technologies 27.78 Bn 25.50 Bn 1.98 Bn -464.00
8 Smith & Nephew 26.99 Bn 26.41 Bn - -
9 Koninklijke Philips 23.92 Bn 20.80 Bn 2.07 Bn 233.00
10 20 3.46 Mn -759,563.02 62,884.00 -45,565.00

Historic Data

Download Data
DateValue
Mar 31, 2026 -45,565.00